Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report

Minerva Ginecol. 2000 Jan-Feb;52(1-2):29-31.

Abstract

The anemia of pregnancy in presence of beta-thalassemia intermedia usually aggravates pregnancy procedure. In the present study we investigated whether the administration of recombinant human erythropoietin (rHuEpo) recombinant human erythropoietin in combination with iron and folic acid may ameliorate blood indices as an alternative choice to blood transfusion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy*
  • Recombinant Proteins
  • beta-Thalassemia / drug therapy*

Substances

  • Recombinant Proteins
  • Erythropoietin